Philadelphia, PA, United States of America

Ioannis Dimitriou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Schering Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioannis Dimitriou. Retrieved from https://idiyas.com/inventor/ioannis-dimitriou-natobn0a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ioannis Dimitriou

Introduction

Ioannis Dimitriou is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of medical research, particularly in the treatment of viral infections. His work focuses on the modulation of cytokine activity, which is crucial for developing effective therapies.

Latest Patents

Dimitriou holds a patent titled "Use of agonists and antagonists of IL-23 in the treatment of viral infection." This patent outlines methods for modulating cytokine activity to treat viral infections. It also provides reagents for screening agonists or antagonists of IL-23, which can be pivotal in advancing therapeutic options.

Career Highlights

Ioannis Dimitriou is associated with Schering Corporation, where he applies his expertise in cytokine modulation. His work at the company has been instrumental in developing innovative treatments for viral infections.

Collaborations

Dimitriou has collaborated with esteemed colleagues such as Peter D. Katsikis and Daniel J. Cua. These partnerships have enhanced the research and development of new therapeutic strategies.

Conclusion

Ioannis Dimitriou's contributions to medical research and his innovative patent demonstrate his commitment to advancing treatment options for viral infections. His work continues to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…